Epoch 43 - Why This Week’s Biotech Bounce is Fake
Market Trends, Deal Terms Tighten, VC Fund Raises Slow
Welcome to the 41 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 831 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. Surpr…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.